Advancing Mitochodrial Medicine with Organoid Technology
Mitochondrial diseases are severe disorders caused by genetic mutations that impair energy production, leading to neurological, muscular, and metabolic dysfunction. With no disease-modifying treatments, research focuses on personalized therapies. Patient-derived organoid models offer a promising platform for drug discovery and precision medicine.
Our Services
We are dedicated to advancing mitochondrial disease research and drug discovery through cutting-edge 3D organoid models and precision medicine approaches.
Disease Modelling
We generate high-fidelity patient-derived organoid models to study mitochondrial dysfunction, enabling disease insights and therapeutic discovery.
Drug Screening
Using high-throughput screening platforms, we test and validate mitochondrial-targeting therapeutics to restore cellular function.
Preclinical Test
We develop 3D brain organoids for precision medicine, offering a physiologically relevant platform for drug and treatment validation.
.png?etag=undefined&sourceContentType=image%2Fpng&ignoreAspectRatio&resize=500%2B500&extract=0%2B134%2B500%2B330)
Our Model Systems
2D Neuronal Model
Patient-derived neurons in monolayer cultures provide a simplified platform for high-throughput drug screening and mitochondrial function analysis.
3D Cortical Organoids
Self-organized brain structures mimicking cortical development and neurodegeneration, providing a platform for disease modeling and therapy testing.
3D Midbrain Organoids
Patient-specific models replicating dopaminergic neuronal networks, ideal for studying mitochondrial dysfunction in neurodegenerative diseases.
Let's work together!
Get in Touch
Paragraphs are the main building blocks of web pages. To change what this one says, just double-click here or hit Edit text. You can change the style here, too.
